Optical coherence tomographic patterns in diabetic macula edema can predict the effects of intravitreal bevacizumab injection as primary treatment

Journal of Ocular Pharmacology and Therapeutics

Volumn 28, Issue 1, 2012, Pages 59-64

  Wu, Pei Chen ^a   Lai, Chien Hsiung ^a,b,c   Chen, Ching Lung ^a,b   Kuo, Chien Neng ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADULT; ARTICLE; CLINICAL ARTICLE; DIABETIC MACULAR EDEMA; DIFFUSE RETINAL THICKENING; FEMALE; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; RETINA MACULA CYSTOID EDEMA; SEROUS RETINAL DETACHMENT; TREATMENT OUTCOME; VISUAL ACUITY; VITREOMACULAR INTERFACE ABNORMALITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; DIABETIC RETINOPATHY; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84863115189     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2011.0070     Document Type: Article

References (31)

1. Otani, T., Kishi, S., and Maruyama, Y. Patterns of diabetic macular edema with optical coherence tomography. Am. J. Ophthalmol. 127:688-693, 1999. (Pubitemid 29266745)
2. Group ETDRSR. Photocoagulation for diabetic macular edema: early treatment diabetic retinopathy study report number 1. Arch. Ophthalmol. 103:1796-1806, 1985.
3. Group ETDRSR. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema: early treatment diabetic retinopathy study report number 2. Ophthalmology 94:761-774, 1987.
4. Michaelides, M., Kaines, A., Hamilton, R.D., et al. A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study): 12-month data: Report 2. Ophthalmology 117:1078-1086.e2, 2010.
5. Haritoglou, C., Kook, D., Neubauer, A., et al. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 26:999-1005, 2006. (Pubitemid 44973218)
6. Arevalo, J.F., Fromow-Guerra, J., Quiroz-Mercado, H., et al. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American collaborative retina study group at 6-month follow-up. Ophthalmology 114:743-750, 2007. (Pubitemid 46483714)
7. Bakri, S.J., Snyder, M.R., Reid, J.M., Pulido, J.S., and Singh, R.J. Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology 114:855-859, 2007.
8. Stewart, M.W. Predicted biologic activity of intravitreal bevacizumab. Retina 27:1196-1200, 2007. (Pubitemid 350211524)
9. Goebel, W., and Kretzchmar-Gross, T. Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina 22:759-767, 2002. (Pubitemid 35462506)
10. Kang, S.W., Park, C.Y., and Ham, D.I. The correlation between fluorescein angiographic and optical coherence to-mographic features in clinically significant diabetic macular edema. Am. J. Ophthalmol. 137:313-322, 2004. (Pubitemid 38221006)
11. Ozdek, S.C., Erdinc, M.A., Gurelik, G., et al. Optical coherence tomographic assessment of diabetic macular edema: comparison with fluorescein angiographic and clinical findings. Ophthalmologica 219:86-92, 2005. (Pubitemid 40529284)
12. Ozdemir, H., Karacorlu, M., and Karacorlu, S. Serous mac-ular detachment in diabetic cystoid macular oedema. Acta Ophthalmol. Scand. 83:63-66, 2005. (Pubitemid 40326423)
13. Panozzo, G., Parolini, B., Gusson, E., et al. Diabetic macular edema: an OCT-based classification. Semin. Ophthalmol. 19:13-20, 2004. (Pubitemid 39658404)
14. Alkuraya, H., Kangave, D., and Abu El-Asrar, A.M. The correlation between optical coherence tomographic features and severity of retinopathy, macular thickness, and visual acuity in diabetic macular edema. Int. Ophthalmol. 26:93-99, 2005. (Pubitemid 44781874)
15. Kim, B.Y., Smith, S.D., and Kaiser, P.K. Optical coherence tomographic patterns of diabetic macular edema. Am. J. Ophthalmol. 142:405-412, 2006.
16. Kim, N.R., Kim, Y.J., Chin, H.S., and Moon, Y.S. Optical coherence tomographic patterns in diabetic macular oedema: prediction of visual outcome after focal laser photocoagulation. Br. J. Ophthalmol. 93:901-905, 2009.
17. Lee, C.M., and Olk, R.J. Modified grid laser photocoagulation for diffuse diabetic macular edema: long-term visual results. Ophthalmology 98:1594-1602, 1991.
18. Roh, M.I., Kim, J.H., and Kwon, O.W. Features of optical coherence tomography are predictive of visual outcomes after intravitreal bevacizumab injection for diabetic macular edema. Ophthalmologica 224:374-380, 2010.
19. Qaum, T., Xu, Q., Joussen, A.M., et al. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest. Ophthal-mol. Vis. Sci. 42:2408-2413, 2001. (Pubitemid 32848873)
20. Network DRCR. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 115:1447-1459.e10, 2008.
21. Campbell, R.J., Coupland, S.G., Buhrmann, R.R., and Kertes, P.J. Optimal optical coherence tomography-based measures in the diagnosis of clinically significant macular edema: retinal volume vs foveal thickness. Arch. Ophthalmol. 125: 619-623, 2007. (Pubitemid 46762721)
22. Yamamoto, S., Yamamoto, T., Hayashi, M., and Takeuchi, S. Morphological and functional analyses of diabetic macular edema by optical coherence tomography and multifocal elec-troretinograms. Graefes Arch. Clin. Exp. Ophthalmol. 239:96-101, 2001. (Pubitemid 32288458)
23. Karatas, M., Ramirez, J.A., and Ophir, A. Diabetic vi-treopapillary traction and macular oedema. Eye (Lond) 19: 676-682, 2005. (Pubitemid 40895483)
24. Fine, B.S., and Brucker, A.J. Macular edema and cystoid macular edema. Am. J. Ophthalmol. 92:466-481, 1981. (Pubitemid 11030201)
25. Yanoff, M., Fine, B.S., Brucker, A.J., and Eagle, R.C. Jr. Pathology of human cystoid macular edema. Surv. Ophthalmol. 28(Suppl):505-511, 1984. (Pubitemid 14076510)
26. Murakami, T., Nishijima, K., Sakamoto, A., et al. Foveal cystoid spaces are associated with enlarged foveal avascular zone and microaneurysms in diabetic macular edema. Ophthalmology 118:359-367, 2011.
27. Roh, M.I., Byeon, S.H., and Kwon, O.W. Repeated in-travitreal injection of bevacizumab for clinically significant diabetic macular edema. Retina 28:1314-1318, 2008.
28. Kook, D., Wolf, A., Kreutzer, T., et al. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema. Retina 28:1053-1060, 2008.
29. Catier, A., Tadayoni, R., Paques, M., et al. Characterization of macular edema from various etiologies by optical coherence tomography. Am. J. Ophthalmol. 140:200-206, 2005.
30. Koleva-Georgieva, D., and Sivkova, N. Assessment of serous macular detachment in eyes with diabetic macular edema by use of spectral-domain optical coherence tomography. Graefes Arch. Clin. Exp. Ophthalmol. 247:1461-1469, 2009.
31. Miyake, T., Sawada, O., Kakinoki, M., et al. Pharmacoki-netics of bevacizumab and its effect on vascular endothelial growth factor after intravitreal injection of bevacizumab in macaque eyes. Invest. Ophthalmol. Vis. Sci. 51:1606-1608, 2010.